Company Filing History:
7 out of 676 
3 out of 2,198 
1 out of 2 Years Active: 1996-2007
Title: The Innovative Journey of Lisa M Fitzgerald
Introduction
Lisa M Fitzgerald, hailing from Germantown, MD, is a prominent inventor with a remarkable portfolio comprising 12 patents. Her groundbreaking work primarily focuses on advancing medical science, particularly in the realms of bone diseases and cancer treatments.
Latest Patents
Among her most notable inventions is the human osteoclast-derived cathepsin, referred to as Cathepsin O. This invention details a human osteoclast-derived cathepsin polypeptide as well as the DNA (RNA) encoding such polypeptides. Additionally, the invention outlines a method for producing this polypeptide through recombinant techniques. The therapeutic potential of her work is significant, as it discloses antibodies, antagonists, and inhibitors of Cathepsin O. These may serve to prevent the action of this polypeptide, making it a promising candidate for treating bone diseases like osteoporosis and addressing cancers, including tumor metastases.
Career Highlights
Throughout her career, Lisa has entrenched herself in the biopharmaceutical landscape, contributing her expertise to innovative companies such as Human Genome Sciences, Inc. Her work has led to significant advancements in therapeutic treatments.
Collaborations
Lisa has had the privilege of collaborating with esteemed colleagues, including Gregg A Hastings and Mark D Adams. These partnerships have enhanced her ability to drive innovation and progress in her field.
Conclusion
Lisa M Fitzgerald stands out as a trailblazer in her field, showcasing the importance of innovation in medical technology. Her dedication to developing therapeutic solutions illustrates the vital role inventors play in improving healthcare outcomes. Her ongoing contributions continue to inspire the next generation of inventors and scientists.